NCT00042822已完成2 期
A Pilot Study Of FR901228, Or Depsipeptide (NSC #630176) For Adult Patients With Advanced Hematologic Cancers
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of FR901228 in treating patients who have myelodysplastic syndrome, acute myeloid leukemia, or non-Hodgkin's lymphoma.
详细描述
OBJECTIVES:
- Determine the pattern of adverse clinical experience in patients with myelodysplastic syndrome, acute myeloid leukemia, or intermediate-grade or follicular non-Hodgkin's lymphoma treated with FR901228 (depsipeptide).
- Determine the disease response in patients treated with this drug.
- Determine the pharmacokinetic and pharmacodynamic correlates of this drug, including measurement of serum plasma levels, H3 and H4 acetylation, apoptosis induction, differentiation, and multidrug-resistant (MDR) phenotype expression in these patients.
OUTLINE: Patients receive FR901228 (depsipeptide) IV over 4 hours on days 1 and 5. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Patients are followed monthly.
PROJECTED ACCRUAL: A total of 12 patients will be accrued for this study within 1 year.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
FR901228 in Treating Patients With Relapsed or Refractory Multiple MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell MyelomaRefractory Plasma Cell MyelomaNCT00066638National Cancer Institute (NCI)50
已完成
2 期
FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal CancerColorectal CancerNCT00077337SWOG Cancer Research Network
终止
2 期
FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant MelanomaMalignant MelanomaMelanomaNCT00104884ECOG-ACRIN Cancer Research Group4
已完成
1 期
FR901228 in Treating Patients With Hematologic CancerLymphomaLeukemiaNCT00024180Ohio State University Comprehensive Cancer Center
终止
2 期
S0400, FR901228 in Treating Patients With Advanced Cancer of the UrotheliumTransitional Cell Cancer of the Renal Pelvis and UreterUrethral CancerBladder CancerNCT00087295SWOG Cancer Research Network6